nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP4A11—Dexamethasone—multiple sclerosis	0.221	0.373	CbGbCtD
Pentamidine—CYP2D6—Fingolimod—multiple sclerosis	0.0609	0.103	CbGbCtD
Pentamidine—CYP1A1—Dexamethasone—multiple sclerosis	0.0403	0.068	CbGbCtD
Pentamidine—CYP3A4—Fingolimod—multiple sclerosis	0.0387	0.0653	CbGbCtD
Pentamidine—CYP2C19—Prednisone—multiple sclerosis	0.0313	0.0527	CbGbCtD
Pentamidine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0249	0.0421	CbGbCtD
Pentamidine—CYP3A5—Dexamethasone—multiple sclerosis	0.0242	0.0408	CbGbCtD
Pentamidine—CYP2C8—Dexamethasone—multiple sclerosis	0.0233	0.0392	CbGbCtD
Pentamidine—CYP2C19—Dexamethasone—multiple sclerosis	0.0195	0.0329	CbGbCtD
Pentamidine—CYP3A4—Triamcinolone—multiple sclerosis	0.0189	0.0319	CbGbCtD
Pentamidine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0182	0.0307	CbGbCtD
Pentamidine—CYP3A4—Betamethasone—multiple sclerosis	0.0162	0.0273	CbGbCtD
Pentamidine—CYP3A4—Prednisolone—multiple sclerosis	0.016	0.027	CbGbCtD
Pentamidine—CYP3A4—Prednisone—multiple sclerosis	0.0151	0.0255	CbGbCtD
Pentamidine—CYP2D6—Dexamethasone—multiple sclerosis	0.0148	0.025	CbGbCtD
Pentamidine—S100B—peripheral nervous system—multiple sclerosis	0.0117	0.26	CbGeAlD
Pentamidine—CYP3A4—Dexamethasone—multiple sclerosis	0.00944	0.0159	CbGbCtD
Pentamidine—S100B—nerve—multiple sclerosis	0.00914	0.203	CbGeAlD
Pentamidine—S100B—brainstem—multiple sclerosis	0.00392	0.0871	CbGeAlD
Pentamidine—S100B—retina—multiple sclerosis	0.00378	0.084	CbGeAlD
Pentamidine—S100B—midbrain—multiple sclerosis	0.0025	0.0555	CbGeAlD
Pentamidine—S100B—spinal cord—multiple sclerosis	0.00244	0.0541	CbGeAlD
Pentamidine—S100B—nervous system—multiple sclerosis	0.00205	0.0456	CbGeAlD
Pentamidine—S100B—central nervous system—multiple sclerosis	0.00198	0.0439	CbGeAlD
Pentamidine—S100B—cerebellum—multiple sclerosis	0.00193	0.0429	CbGeAlD
Pentamidine—S100B—brain—multiple sclerosis	0.00157	0.0349	CbGeAlD
Pentamidine—CYP2D6—brainstem—multiple sclerosis	0.000612	0.0136	CbGeAlD
Pentamidine—CYP1A1—nervous system—multiple sclerosis	0.000444	0.00986	CbGeAlD
Pentamidine—CYP1A1—central nervous system—multiple sclerosis	0.000427	0.00949	CbGeAlD
Pentamidine—CYP2C8—brain—multiple sclerosis	0.000368	0.00816	CbGeAlD
Pentamidine—CYP1A1—brain—multiple sclerosis	0.000339	0.00753	CbGeAlD
Pentamidine—CYP3A4—nervous system—multiple sclerosis	0.000326	0.00723	CbGeAlD
Pentamidine—CYP2D6—nervous system—multiple sclerosis	0.000321	0.00712	CbGeAlD
Pentamidine—CYP3A4—central nervous system—multiple sclerosis	0.000314	0.00696	CbGeAlD
Pentamidine—CYP2D6—central nervous system—multiple sclerosis	0.000309	0.00685	CbGeAlD
Pentamidine—CYP2D6—cerebellum—multiple sclerosis	0.000302	0.0067	CbGeAlD
Pentamidine—CYP2D6—brain—multiple sclerosis	0.000245	0.00544	CbGeAlD
Pentamidine—Urticaria—Mitoxantrone—multiple sclerosis	0.0002	0.000756	CcSEcCtD
Pentamidine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000199	0.000753	CcSEcCtD
Pentamidine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000199	0.000753	CcSEcCtD
Pentamidine—Myalgia—Triamcinolone—multiple sclerosis	0.000198	0.000749	CcSEcCtD
Pentamidine—Vomiting—Azathioprine—multiple sclerosis	0.000198	0.000749	CcSEcCtD
Pentamidine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000197	0.000748	CcSEcCtD
Pentamidine—Myalgia—Methylprednisolone—multiple sclerosis	0.000197	0.000748	CcSEcCtD
Pentamidine—Anxiety—Methylprednisolone—multiple sclerosis	0.000197	0.000745	CcSEcCtD
Pentamidine—Drowsiness—Methotrexate—multiple sclerosis	0.000196	0.000744	CcSEcCtD
Pentamidine—Rash—Azathioprine—multiple sclerosis	0.000196	0.000743	CcSEcCtD
Pentamidine—Dermatitis—Azathioprine—multiple sclerosis	0.000196	0.000742	CcSEcCtD
Pentamidine—Flushing—Prednisone—multiple sclerosis	0.000196	0.000741	CcSEcCtD
Pentamidine—Discomfort—Triamcinolone—multiple sclerosis	0.000195	0.00074	CcSEcCtD
Pentamidine—Discomfort—Methylprednisolone—multiple sclerosis	0.000195	0.000739	CcSEcCtD
Pentamidine—Headache—Azathioprine—multiple sclerosis	0.000195	0.000738	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000195	0.000737	CcSEcCtD
Pentamidine—S100B—Innate Immune System—CD28—multiple sclerosis	0.000193	0.00197	CbGpPWpGaD
Pentamidine—Dry mouth—Triamcinolone—multiple sclerosis	0.000193	0.000733	CcSEcCtD
Pentamidine—Renal failure—Methotrexate—multiple sclerosis	0.000193	0.000731	CcSEcCtD
Pentamidine—Angioedema—Betamethasone—multiple sclerosis	0.000192	0.00073	CcSEcCtD
Pentamidine—Angioedema—Dexamethasone—multiple sclerosis	0.000192	0.00073	CcSEcCtD
Pentamidine—S100B—MyD88 cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000192	0.00196	CbGpPWpGaD
Pentamidine—Stomatitis—Methotrexate—multiple sclerosis	0.000191	0.000725	CcSEcCtD
Pentamidine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000191	0.000723	CcSEcCtD
Pentamidine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.000191	0.00195	CbGpPWpGaD
Pentamidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000191	0.000723	CcSEcCtD
Pentamidine—S100B—Innate Immune System—CCR2—multiple sclerosis	0.00019	0.00194	CbGpPWpGaD
Pentamidine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000189	0.000718	CcSEcCtD
Pentamidine—Vertigo—Betamethasone—multiple sclerosis	0.000189	0.000717	CcSEcCtD
Pentamidine—Vertigo—Dexamethasone—multiple sclerosis	0.000189	0.000717	CcSEcCtD
Pentamidine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000189	0.000717	CcSEcCtD
Pentamidine—Syncope—Betamethasone—multiple sclerosis	0.000189	0.000716	CcSEcCtD
Pentamidine—Syncope—Dexamethasone—multiple sclerosis	0.000189	0.000716	CcSEcCtD
Pentamidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000188	0.00192	CbGpPWpGaD
Pentamidine—Arrhythmia—Prednisone—multiple sclerosis	0.000188	0.000714	CcSEcCtD
Pentamidine—Infection—Triamcinolone—multiple sclerosis	0.000188	0.000714	CcSEcCtD
Pentamidine—Infection—Methylprednisolone—multiple sclerosis	0.000188	0.000712	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—MAPK1—multiple sclerosis	0.000188	0.00191	CbGpPWpGaD
Pentamidine—S100B—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000187	0.00191	CbGpPWpGaD
Pentamidine—Haematuria—Methotrexate—multiple sclerosis	0.000187	0.000709	CcSEcCtD
Pentamidine—Shock—Triamcinolone—multiple sclerosis	0.000186	0.000707	CcSEcCtD
Pentamidine—Insomnia—Prednisolone—multiple sclerosis	0.000186	0.000706	CcSEcCtD
Pentamidine—Shock—Methylprednisolone—multiple sclerosis	0.000186	0.000705	CcSEcCtD
Pentamidine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000186	0.0019	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000186	0.0019	CbGpPWpGaD
Pentamidine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000185	0.000702	CcSEcCtD
Pentamidine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000185	0.000702	CcSEcCtD
Pentamidine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000185	0.000701	CcSEcCtD
Pentamidine—Paraesthesia—Prednisolone—multiple sclerosis	0.000185	0.000701	CcSEcCtD
Pentamidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000185	0.000701	CcSEcCtD
Pentamidine—Nausea—Azathioprine—multiple sclerosis	0.000185	0.0007	CcSEcCtD
Pentamidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000185	0.000699	CcSEcCtD
Pentamidine—Erythema—Prednisone—multiple sclerosis	0.000183	0.000695	CcSEcCtD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000183	0.00187	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000183	0.00187	CbGpPWpGaD
Pentamidine—Convulsion—Betamethasone—multiple sclerosis	0.000183	0.000692	CcSEcCtD
Pentamidine—Convulsion—Dexamethasone—multiple sclerosis	0.000183	0.000692	CcSEcCtD
Pentamidine—Hypertension—Betamethasone—multiple sclerosis	0.000182	0.000689	CcSEcCtD
Pentamidine—Hypertension—Dexamethasone—multiple sclerosis	0.000182	0.000689	CcSEcCtD
Pentamidine—S100B—Immune System—CBLB—multiple sclerosis	0.000182	0.00186	CbGpPWpGaD
Pentamidine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.000181	0.00184	CbGpPWpGaD
Pentamidine—Asthenia—Mitoxantrone—multiple sclerosis	0.00018	0.000683	CcSEcCtD
Pentamidine—Myalgia—Betamethasone—multiple sclerosis	0.000179	0.00068	CcSEcCtD
Pentamidine—Myalgia—Dexamethasone—multiple sclerosis	0.000179	0.00068	CcSEcCtD
Pentamidine—Anxiety—Dexamethasone—multiple sclerosis	0.000179	0.000677	CcSEcCtD
Pentamidine—Anxiety—Betamethasone—multiple sclerosis	0.000179	0.000677	CcSEcCtD
Pentamidine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000178	0.00181	CbGpPWpGaD
Pentamidine—Discomfort—Betamethasone—multiple sclerosis	0.000177	0.000672	CcSEcCtD
Pentamidine—Discomfort—Dexamethasone—multiple sclerosis	0.000177	0.000672	CcSEcCtD
Pentamidine—Hypotension—Methylprednisolone—multiple sclerosis	0.000177	0.00067	CcSEcCtD
Pentamidine—Pain—Prednisolone—multiple sclerosis	0.000176	0.000668	CcSEcCtD
Pentamidine—Hepatitis—Methotrexate—multiple sclerosis	0.000176	0.000668	CcSEcCtD
Pentamidine—S100B—Innate Immune System—IFNB1—multiple sclerosis	0.000175	0.00179	CbGpPWpGaD
Pentamidine—Pharyngitis—Methotrexate—multiple sclerosis	0.000175	0.000663	CcSEcCtD
Pentamidine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000174	0.00177	CbGpPWpGaD
Pentamidine—Vision blurred—Prednisone—multiple sclerosis	0.000173	0.000655	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000173	0.000654	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—TAGAP—multiple sclerosis	0.000172	0.00176	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000172	0.000653	CcSEcCtD
Pentamidine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000172	0.000652	CcSEcCtD
Pentamidine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000172	0.000652	CcSEcCtD
Pentamidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000172	0.000651	CcSEcCtD
Pentamidine—Insomnia—Triamcinolone—multiple sclerosis	0.000171	0.00065	CcSEcCtD
Pentamidine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000171	0.00175	CbGpPWpGaD
Pentamidine—Insomnia—Methylprednisolone—multiple sclerosis	0.000171	0.000648	CcSEcCtD
Pentamidine—Infection—Betamethasone—multiple sclerosis	0.000171	0.000647	CcSEcCtD
Pentamidine—Infection—Dexamethasone—multiple sclerosis	0.000171	0.000647	CcSEcCtD
Pentamidine—S100B—MyD88-independent cascade—IL6—multiple sclerosis	0.00017	0.00174	CbGpPWpGaD
Pentamidine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00017	0.000645	CcSEcCtD
Pentamidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00017	0.000644	CcSEcCtD
Pentamidine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00017	0.000644	CcSEcCtD
Pentamidine—Anaemia—Prednisone—multiple sclerosis	0.00017	0.000643	CcSEcCtD
Pentamidine—Shock—Betamethasone—multiple sclerosis	0.000169	0.000641	CcSEcCtD
Pentamidine—Shock—Dexamethasone—multiple sclerosis	0.000169	0.000641	CcSEcCtD
Pentamidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000169	0.00064	CcSEcCtD
Pentamidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000168	0.000638	CcSEcCtD
Pentamidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000168	0.000638	CcSEcCtD
Pentamidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000168	0.000636	CcSEcCtD
Pentamidine—Tachycardia—Betamethasone—multiple sclerosis	0.000168	0.000636	CcSEcCtD
Pentamidine—Angioedema—Prednisone—multiple sclerosis	0.000168	0.000635	CcSEcCtD
Pentamidine—S100B—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000167	0.0017	CbGpPWpGaD
Pentamidine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000167	0.000632	CcSEcCtD
Pentamidine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000167	0.000631	CcSEcCtD
Pentamidine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000166	0.000631	CcSEcCtD
Pentamidine—Vertigo—Prednisone—multiple sclerosis	0.000165	0.000625	CcSEcCtD
Pentamidine—Syncope—Prednisone—multiple sclerosis	0.000165	0.000624	CcSEcCtD
Pentamidine—Anorexia—Betamethasone—multiple sclerosis	0.000164	0.000621	CcSEcCtD
Pentamidine—Anorexia—Dexamethasone—multiple sclerosis	0.000164	0.000621	CcSEcCtD
Pentamidine—Urticaria—Prednisolone—multiple sclerosis	0.000164	0.00062	CcSEcCtD
Pentamidine—Fatigue—Triamcinolone—multiple sclerosis	0.000163	0.000619	CcSEcCtD
Pentamidine—Fatigue—Methylprednisolone—multiple sclerosis	0.000163	0.000618	CcSEcCtD
Pentamidine—Pain—Triamcinolone—multiple sclerosis	0.000162	0.000614	CcSEcCtD
Pentamidine—S100B—Immune System—MX1—multiple sclerosis	0.000161	0.00165	CbGpPWpGaD
Pentamidine—Loss of consciousness—Prednisone—multiple sclerosis	0.000161	0.000611	CcSEcCtD
Pentamidine—Hypotension—Dexamethasone—multiple sclerosis	0.000161	0.000609	CcSEcCtD
Pentamidine—Hypotension—Betamethasone—multiple sclerosis	0.000161	0.000609	CcSEcCtD
Pentamidine—Vomiting—Mitoxantrone—multiple sclerosis	0.00016	0.000605	CcSEcCtD
Pentamidine—Convulsion—Prednisone—multiple sclerosis	0.000159	0.000603	CcSEcCtD
Pentamidine—Hypertension—Prednisone—multiple sclerosis	0.000158	0.0006	CcSEcCtD
Pentamidine—Rash—Mitoxantrone—multiple sclerosis	0.000158	0.0006	CcSEcCtD
Pentamidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000158	0.0006	CcSEcCtD
Pentamidine—Chills—Methotrexate—multiple sclerosis	0.000158	0.000599	CcSEcCtD
Pentamidine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00161	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00161	CbGpPWpGaD
Pentamidine—Headache—Mitoxantrone—multiple sclerosis	0.000157	0.000596	CcSEcCtD
Pentamidine—S100B—Signaling by ERBB4—MAPK1—multiple sclerosis	0.000157	0.00161	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000157	0.000594	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000157	0.000594	CcSEcCtD
Pentamidine—S100B—Immune System—HLA-DRA—multiple sclerosis	0.000156	0.00159	CbGpPWpGaD
Pentamidine—Myalgia—Prednisone—multiple sclerosis	0.000156	0.000592	CcSEcCtD
Pentamidine—Arthralgia—Prednisone—multiple sclerosis	0.000156	0.000592	CcSEcCtD
Pentamidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000156	0.000592	CcSEcCtD
Pentamidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000156	0.000591	CcSEcCtD
Pentamidine—Anxiety—Prednisone—multiple sclerosis	0.000156	0.00059	CcSEcCtD
Pentamidine—Insomnia—Dexamethasone—multiple sclerosis	0.000156	0.000589	CcSEcCtD
Pentamidine—Insomnia—Betamethasone—multiple sclerosis	0.000156	0.000589	CcSEcCtD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000155	0.00158	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000155	0.00158	CbGpPWpGaD
Pentamidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000155	0.000586	CcSEcCtD
Pentamidine—Paraesthesia—Betamethasone—multiple sclerosis	0.000154	0.000585	CcSEcCtD
Pentamidine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000154	0.000585	CcSEcCtD
Pentamidine—Discomfort—Prednisone—multiple sclerosis	0.000154	0.000585	CcSEcCtD
Pentamidine—Erythema—Methotrexate—multiple sclerosis	0.000153	0.000581	CcSEcCtD
Pentamidine—S100B—Activated TLR4 signalling—IL6—multiple sclerosis	0.000153	0.00156	CbGpPWpGaD
Pentamidine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000152	0.000575	CcSEcCtD
Pentamidine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000151	0.000574	CcSEcCtD
Pentamidine—Dyspepsia—Betamethasone—multiple sclerosis	0.000151	0.000574	CcSEcCtD
Pentamidine—CYP4A11—Metabolism—SRM—multiple sclerosis	0.000151	0.00154	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—S1PR1—multiple sclerosis	0.000151	0.00154	CbGpPWpGaD
Pentamidine—Urticaria—Triamcinolone—multiple sclerosis	0.000151	0.000571	CcSEcCtD
Pentamidine—Urticaria—Methylprednisolone—multiple sclerosis	0.00015	0.000569	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—multiple sclerosis	0.00015	0.000569	CcSEcCtD
Pentamidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00015	0.000568	CcSEcCtD
Pentamidine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00015	0.000568	CcSEcCtD
Pentamidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000149	0.000567	CcSEcCtD
Pentamidine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000149	0.000567	CcSEcCtD
Pentamidine—Decreased appetite—Betamethasone—multiple sclerosis	0.000149	0.000567	CcSEcCtD
Pentamidine—Nausea—Mitoxantrone—multiple sclerosis	0.000149	0.000565	CcSEcCtD
Pentamidine—Infection—Prednisone—multiple sclerosis	0.000149	0.000564	CcSEcCtD
Pentamidine—Fatigue—Dexamethasone—multiple sclerosis	0.000148	0.000562	CcSEcCtD
Pentamidine—Fatigue—Betamethasone—multiple sclerosis	0.000148	0.000562	CcSEcCtD
Pentamidine—S100B—Immune System—NOD1—multiple sclerosis	0.000147	0.0015	CbGpPWpGaD
Pentamidine—Shock—Prednisone—multiple sclerosis	0.000147	0.000558	CcSEcCtD
Pentamidine—Pain—Dexamethasone—multiple sclerosis	0.000147	0.000557	CcSEcCtD
Pentamidine—Pain—Betamethasone—multiple sclerosis	0.000147	0.000557	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—GPC5—multiple sclerosis	0.000147	0.00149	CbGpPWpGaD
Pentamidine—Tachycardia—Prednisone—multiple sclerosis	0.000146	0.000554	CcSEcCtD
Pentamidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000145	0.00148	CbGpPWpGaD
Pentamidine—Vision blurred—Methotrexate—multiple sclerosis	0.000145	0.000548	CcSEcCtD
Pentamidine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000144	0.00147	CbGpPWpGaD
Pentamidine—Anorexia—Prednisone—multiple sclerosis	0.000143	0.000541	CcSEcCtD
Pentamidine—S100B—Immune System—MALT1—multiple sclerosis	0.000142	0.00145	CbGpPWpGaD
Pentamidine—Anaemia—Methotrexate—multiple sclerosis	0.000142	0.000537	CcSEcCtD
Pentamidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000142	0.000537	CcSEcCtD
Pentamidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000142	0.000537	CcSEcCtD
Pentamidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000141	0.000533	CcSEcCtD
Pentamidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000141	0.000533	CcSEcCtD
Pentamidine—S100B—Immune System—IRF5—multiple sclerosis	0.00014	0.00143	CbGpPWpGaD
Pentamidine—CYP4A11—Biological oxidations—POMC—multiple sclerosis	0.00014	0.00143	CbGpPWpGaD
Pentamidine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00014	0.000529	CcSEcCtD
Pentamidine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000139	0.000528	CcSEcCtD
Pentamidine—S100B—Innate Immune System—CD86—multiple sclerosis	0.000138	0.00141	CbGpPWpGaD
Pentamidine—Vertigo—Methotrexate—multiple sclerosis	0.000138	0.000522	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—multiple sclerosis	0.000137	0.00052	CcSEcCtD
Pentamidine—Urticaria—Betamethasone—multiple sclerosis	0.000137	0.000518	CcSEcCtD
Pentamidine—Urticaria—Dexamethasone—multiple sclerosis	0.000137	0.000518	CcSEcCtD
Pentamidine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000137	0.00139	CbGpPWpGaD
Pentamidine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000136	0.000517	CcSEcCtD
Pentamidine—Dizziness—Prednisolone—multiple sclerosis	0.000136	0.000516	CcSEcCtD
Pentamidine—Asthenia—Triamcinolone—multiple sclerosis	0.000136	0.000515	CcSEcCtD
Pentamidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000136	0.000515	CcSEcCtD
Pentamidine—Body temperature increased—Betamethasone—multiple sclerosis	0.000136	0.000515	CcSEcCtD
Pentamidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000136	0.000515	CcSEcCtD
Pentamidine—Abdominal pain—Betamethasone—multiple sclerosis	0.000136	0.000515	CcSEcCtD
Pentamidine—Asthenia—Methylprednisolone—multiple sclerosis	0.000136	0.000514	CcSEcCtD
Pentamidine—Insomnia—Prednisone—multiple sclerosis	0.000135	0.000513	CcSEcCtD
Pentamidine—Paraesthesia—Prednisone—multiple sclerosis	0.000134	0.00051	CcSEcCtD
Pentamidine—Pruritus—Triamcinolone—multiple sclerosis	0.000134	0.000508	CcSEcCtD
Pentamidine—Cough—Methotrexate—multiple sclerosis	0.000134	0.000507	CcSEcCtD
Pentamidine—S100B—Immune System—IRF8—multiple sclerosis	0.000134	0.00137	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-G—multiple sclerosis	0.000134	0.00137	CbGpPWpGaD
Pentamidine—S100B—Immune System—IFIH1—multiple sclerosis	0.000134	0.00137	CbGpPWpGaD
Pentamidine—Pruritus—Methylprednisolone—multiple sclerosis	0.000134	0.000507	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—multiple sclerosis	0.000133	0.000504	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000133	0.00135	CbGpPWpGaD
Pentamidine—Dyspepsia—Prednisone—multiple sclerosis	0.000132	0.0005	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—multiple sclerosis	0.000131	0.000495	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—multiple sclerosis	0.000131	0.000495	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—multiple sclerosis	0.000131	0.000495	CcSEcCtD
Pentamidine—Decreased appetite—Prednisone—multiple sclerosis	0.00013	0.000493	CcSEcCtD
Pentamidine—Rash—Prednisolone—multiple sclerosis	0.00013	0.000492	CcSEcCtD
Pentamidine—Dermatitis—Prednisolone—multiple sclerosis	0.00013	0.000492	CcSEcCtD
Pentamidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000129	0.00049	CcSEcCtD
Pentamidine—Fatigue—Prednisone—multiple sclerosis	0.000129	0.000489	CcSEcCtD
Pentamidine—Headache—Prednisolone—multiple sclerosis	0.000129	0.000489	CcSEcCtD
Pentamidine—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000129	0.00132	CbGpPWpGaD
Pentamidine—Discomfort—Methotrexate—multiple sclerosis	0.000129	0.000489	CcSEcCtD
Pentamidine—S100B—Innate Immune System—HLA-B—multiple sclerosis	0.000129	0.00131	CbGpPWpGaD
Pentamidine—S100B—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000128	0.00131	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RGS1—multiple sclerosis	0.000128	0.00131	CbGpPWpGaD
Pentamidine—Constipation—Prednisone—multiple sclerosis	0.000128	0.000485	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—multiple sclerosis	0.000126	0.000478	CcSEcCtD
Pentamidine—Dizziness—Triamcinolone—multiple sclerosis	0.000125	0.000475	CcSEcCtD
Pentamidine—S100B—Immune System—TNFAIP3—multiple sclerosis	0.000125	0.00128	CbGpPWpGaD
Pentamidine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000125	0.000474	CcSEcCtD
Pentamidine—Dizziness—Methylprednisolone—multiple sclerosis	0.000125	0.000474	CcSEcCtD
Pentamidine—Infection—Methotrexate—multiple sclerosis	0.000124	0.000471	CcSEcCtD
Pentamidine—Feeling abnormal—Prednisone—multiple sclerosis	0.000123	0.000468	CcSEcCtD
Pentamidine—Asthenia—Dexamethasone—multiple sclerosis	0.000123	0.000468	CcSEcCtD
Pentamidine—Asthenia—Betamethasone—multiple sclerosis	0.000123	0.000468	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000123	0.000464	CcSEcCtD
Pentamidine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000122	0.000464	CcSEcCtD
Pentamidine—Nausea—Prednisolone—multiple sclerosis	0.000122	0.000464	CcSEcCtD
Pentamidine—Pruritus—Dexamethasone—multiple sclerosis	0.000122	0.000461	CcSEcCtD
Pentamidine—Pruritus—Betamethasone—multiple sclerosis	0.000122	0.000461	CcSEcCtD
Pentamidine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000122	0.00124	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000122	0.00124	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GPR65—multiple sclerosis	0.000121	0.00124	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—IL6—multiple sclerosis	0.000121	0.00123	CbGpPWpGaD
Pentamidine—Vomiting—Triamcinolone—multiple sclerosis	0.00012	0.000457	CcSEcCtD
Pentamidine—Vomiting—Methylprednisolone—multiple sclerosis	0.00012	0.000456	CcSEcCtD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00012	0.00122	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00012	0.00122	CbGpPWpGaD
Pentamidine—Rash—Triamcinolone—multiple sclerosis	0.000119	0.000453	CcSEcCtD
Pentamidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000119	0.000452	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—multiple sclerosis	0.000119	0.000452	CcSEcCtD
Pentamidine—Rash—Methylprednisolone—multiple sclerosis	0.000119	0.000452	CcSEcCtD
Pentamidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000119	0.000451	CcSEcCtD
Pentamidine—Urticaria—Prednisone—multiple sclerosis	0.000119	0.000451	CcSEcCtD
Pentamidine—Headache—Triamcinolone—multiple sclerosis	0.000119	0.00045	CcSEcCtD
Pentamidine—Headache—Methylprednisolone—multiple sclerosis	0.000118	0.000449	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000118	0.00121	CbGpPWpGaD
Pentamidine—Abdominal pain—Prednisone—multiple sclerosis	0.000118	0.000449	CcSEcCtD
Pentamidine—Body temperature increased—Prednisone—multiple sclerosis	0.000118	0.000449	CcSEcCtD
Pentamidine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000118	0.00121	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000118	0.0012	CbGpPWpGaD
Pentamidine—Diarrhoea—Betamethasone—multiple sclerosis	0.000118	0.000446	CcSEcCtD
Pentamidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000118	0.000446	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—multiple sclerosis	0.000117	0.000443	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000114	0.000432	CcSEcCtD
Pentamidine—Dizziness—Dexamethasone—multiple sclerosis	0.000114	0.000431	CcSEcCtD
Pentamidine—Dizziness—Betamethasone—multiple sclerosis	0.000114	0.000431	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—multiple sclerosis	0.000113	0.000429	CcSEcCtD
Pentamidine—S100B—Immune System—CD28—multiple sclerosis	0.000113	0.00115	CbGpPWpGaD
Pentamidine—Nausea—Triamcinolone—multiple sclerosis	0.000113	0.000427	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—multiple sclerosis	0.000112	0.000426	CcSEcCtD
Pentamidine—Nausea—Methylprednisolone—multiple sclerosis	0.000112	0.000426	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—multiple sclerosis	0.000112	0.000423	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—multiple sclerosis	0.000111	0.000422	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—CCR1—multiple sclerosis	0.000111	0.00113	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL13—multiple sclerosis	0.000111	0.00113	CbGpPWpGaD
Pentamidine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000111	0.00113	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTPRC—multiple sclerosis	0.000111	0.00113	CbGpPWpGaD
Pentamidine—S100B—Immune System—CCR2—multiple sclerosis	0.000111	0.00113	CbGpPWpGaD
Pentamidine—Hypersensitivity—Prednisone—multiple sclerosis	0.00011	0.000418	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—multiple sclerosis	0.00011	0.000418	CcSEcCtD
Pentamidine—Vomiting—Dexamethasone—multiple sclerosis	0.000109	0.000414	CcSEcCtD
Pentamidine—Vomiting—Betamethasone—multiple sclerosis	0.000109	0.000414	CcSEcCtD
Pentamidine—S100B—Innate Immune System—TLR4—multiple sclerosis	0.000109	0.00111	CbGpPWpGaD
Pentamidine—Decreased appetite—Methotrexate—multiple sclerosis	0.000109	0.000412	CcSEcCtD
Pentamidine—Rash—Dexamethasone—multiple sclerosis	0.000108	0.000411	CcSEcCtD
Pentamidine—Rash—Betamethasone—multiple sclerosis	0.000108	0.000411	CcSEcCtD
Pentamidine—Dermatitis—Dexamethasone—multiple sclerosis	0.000108	0.000411	CcSEcCtD
Pentamidine—Dermatitis—Betamethasone—multiple sclerosis	0.000108	0.000411	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—multiple sclerosis	0.000108	0.000409	CcSEcCtD
Pentamidine—Headache—Dexamethasone—multiple sclerosis	0.000108	0.000408	CcSEcCtD
Pentamidine—Headache—Betamethasone—multiple sclerosis	0.000108	0.000408	CcSEcCtD
Pentamidine—Asthenia—Prednisone—multiple sclerosis	0.000107	0.000407	CcSEcCtD
Pentamidine—Pain—Methotrexate—multiple sclerosis	0.000107	0.000406	CcSEcCtD
Pentamidine—S100B—Immune System—HLA-DPB1—multiple sclerosis	0.000107	0.00109	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP24A1—multiple sclerosis	0.000106	0.00109	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP27B1—multiple sclerosis	0.000106	0.00109	CbGpPWpGaD
Pentamidine—Pruritus—Prednisone—multiple sclerosis	0.000106	0.000402	CcSEcCtD
Pentamidine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00108	CbGpPWpGaD
Pentamidine—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000105	0.00107	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000104	0.00106	CbGpPWpGaD
Pentamidine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000103	0.000391	CcSEcCtD
Pentamidine—S100B—Immune System—CD40—multiple sclerosis	0.000103	0.00105	CbGpPWpGaD
Pentamidine—S100B—Immune System—ITGA4—multiple sclerosis	0.000103	0.00105	CbGpPWpGaD
Pentamidine—Diarrhoea—Prednisone—multiple sclerosis	0.000102	0.000388	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000102	0.000388	CcSEcCtD
Pentamidine—S100B—Immune System—IFNB1—multiple sclerosis	0.000102	0.00104	CbGpPWpGaD
Pentamidine—Nausea—Betamethasone—multiple sclerosis	0.000102	0.000387	CcSEcCtD
Pentamidine—Nausea—Dexamethasone—multiple sclerosis	0.000102	0.000387	CcSEcCtD
Pentamidine—S100B—Immune System—CTLA4—multiple sclerosis	0.000101	0.00103	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CD80—multiple sclerosis	0.000101	0.00103	CbGpPWpGaD
Pentamidine—Urticaria—Methotrexate—multiple sclerosis	9.94e-05	0.000377	CcSEcCtD
Pentamidine—Dizziness—Prednisone—multiple sclerosis	9.9e-05	0.000375	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—multiple sclerosis	9.89e-05	0.000375	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—multiple sclerosis	9.89e-05	0.000375	CcSEcCtD
Pentamidine—CYP4A11—Metabolism—GPC5—multiple sclerosis	9.73e-05	0.000993	CbGpPWpGaD
Pentamidine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.71e-05	0.000991	CbGpPWpGaD
Pentamidine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.59e-05	0.000978	CbGpPWpGaD
Pentamidine—Vomiting—Prednisone—multiple sclerosis	9.52e-05	0.000361	CcSEcCtD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.48e-05	0.000968	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.48e-05	0.000968	CbGpPWpGaD
Pentamidine—Rash—Prednisone—multiple sclerosis	9.44e-05	0.000358	CcSEcCtD
Pentamidine—Dermatitis—Prednisone—multiple sclerosis	9.43e-05	0.000358	CcSEcCtD
Pentamidine—Headache—Prednisone—multiple sclerosis	9.38e-05	0.000356	CcSEcCtD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	9.22e-05	0.000941	CbGpPWpGaD
Pentamidine—Hypersensitivity—Methotrexate—multiple sclerosis	9.22e-05	0.000349	CcSEcCtD
Pentamidine—CYP4A11—NRF2 pathway—TGFB1—multiple sclerosis	9.2e-05	0.000939	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	9.2e-05	0.000939	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	9.02e-05	0.000921	CbGpPWpGaD
Pentamidine—Asthenia—Methotrexate—multiple sclerosis	8.98e-05	0.00034	CcSEcCtD
Pentamidine—S100B—Immune System—VCAM1—multiple sclerosis	8.95e-05	0.000913	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-DQA1—multiple sclerosis	8.93e-05	0.000911	CbGpPWpGaD
Pentamidine—Nausea—Prednisone—multiple sclerosis	8.89e-05	0.000337	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—multiple sclerosis	8.85e-05	0.000336	CcSEcCtD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.69e-05	0.000887	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.69e-05	0.000887	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.59e-05	0.000877	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.59e-05	0.000877	CbGpPWpGaD
Pentamidine—Diarrhoea—Methotrexate—multiple sclerosis	8.56e-05	0.000325	CcSEcCtD
Pentamidine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.56e-05	0.000873	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—TYK2—multiple sclerosis	8.5e-05	0.000867	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.46e-05	0.000864	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-DQB1—multiple sclerosis	8.35e-05	0.000852	CbGpPWpGaD
Pentamidine—Dizziness—Methotrexate—multiple sclerosis	8.27e-05	0.000314	CcSEcCtD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.23e-05	0.000839	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—RRM1—multiple sclerosis	8.07e-05	0.000823	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD86—multiple sclerosis	8.04e-05	0.00082	CbGpPWpGaD
Pentamidine—Vomiting—Methotrexate—multiple sclerosis	7.96e-05	0.000302	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—CCL3—multiple sclerosis	7.91e-05	0.000807	CbGpPWpGaD
Pentamidine—Rash—Methotrexate—multiple sclerosis	7.89e-05	0.000299	CcSEcCtD
Pentamidine—S100B—Immune System—CD40LG—multiple sclerosis	7.89e-05	0.000805	CbGpPWpGaD
Pentamidine—Dermatitis—Methotrexate—multiple sclerosis	7.88e-05	0.000299	CcSEcCtD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.87e-05	0.000803	CbGpPWpGaD
Pentamidine—Headache—Methotrexate—multiple sclerosis	7.84e-05	0.000297	CcSEcCtD
Pentamidine—S100B—Immune System—CD8A—multiple sclerosis	7.8e-05	0.000796	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.76e-05	0.000792	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.76e-05	0.000792	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CD4—multiple sclerosis	7.69e-05	0.000785	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTGER4—multiple sclerosis	7.62e-05	0.000777	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.55e-05	0.00077	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.52e-05	0.000767	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-B—multiple sclerosis	7.5e-05	0.000765	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PGR—multiple sclerosis	7.5e-05	0.000765	CbGpPWpGaD
Pentamidine—Nausea—Methotrexate—multiple sclerosis	7.43e-05	0.000282	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—CXCR3—multiple sclerosis	7.36e-05	0.00075	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CD28—multiple sclerosis	7.29e-05	0.000743	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCR2—multiple sclerosis	7.16e-05	0.00073	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2RA—multiple sclerosis	7.03e-05	0.000717	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-A—multiple sclerosis	6.95e-05	0.000709	CbGpPWpGaD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.67e-05	0.00068	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CNR1—multiple sclerosis	6.6e-05	0.000674	CbGpPWpGaD
Pentamidine—S100B—Immune System—TLR4—multiple sclerosis	6.36e-05	0.000649	CbGpPWpGaD
Pentamidine—S100B—Immune System—HLA-DRB1—multiple sclerosis	6.35e-05	0.000648	CbGpPWpGaD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.35e-05	0.000648	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SRM—multiple sclerosis	6.34e-05	0.000647	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.26e-05	0.000638	CbGpPWpGaD
Pentamidine—S100B—Immune System—ICAM1—multiple sclerosis	6.09e-05	0.000622	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.05e-05	0.000617	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.05e-05	0.000617	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SRM—multiple sclerosis	5.99e-05	0.000612	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL10—multiple sclerosis	5.95e-05	0.000607	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.88e-05	0.0006	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.88e-05	0.0006	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.87e-05	0.000599	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD80—multiple sclerosis	5.87e-05	0.000599	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.75e-05	0.000587	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—POMC—multiple sclerosis	5.56e-05	0.000567	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SRM—multiple sclerosis	5.5e-05	0.000561	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.48e-05	0.000559	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.48e-05	0.000559	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—MAPK1—multiple sclerosis	5.41e-05	0.000552	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.38e-05	0.000548	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CD86—multiple sclerosis	5.2e-05	0.00053	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.15e-05	0.000525	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCL5—multiple sclerosis	5.12e-05	0.000522	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.09e-05	0.00052	CbGpPWpGaD
Pentamidine—S100B—Immune System—TYK2—multiple sclerosis	4.95e-05	0.000505	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SRM—multiple sclerosis	4.91e-05	0.000501	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.9e-05	0.0005	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SPP1—multiple sclerosis	4.74e-05	0.000484	CbGpPWpGaD
Pentamidine—S100B—Immune System—IFNG—multiple sclerosis	4.64e-05	0.000473	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—BCHE—multiple sclerosis	4.63e-05	0.000473	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCR5—multiple sclerosis	4.61e-05	0.00047	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.55e-05	0.000464	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2RA—multiple sclerosis	4.54e-05	0.000464	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SRM—multiple sclerosis	4.51e-05	0.00046	CbGpPWpGaD
Pentamidine—S100B—Immune System—CD4—multiple sclerosis	4.48e-05	0.000457	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.47e-05	0.000456	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.47e-05	0.000456	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	4.22e-05	0.000431	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	4.22e-05	0.000431	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APOE—multiple sclerosis	4.19e-05	0.000428	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.18e-05	0.000427	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—IL6—multiple sclerosis	4.16e-05	0.000424	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL1B—multiple sclerosis	4.14e-05	0.000422	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.13e-05	0.000421	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—multiple sclerosis	4.12e-05	0.00042	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.09e-05	0.000417	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.87e-05	0.000395	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.87e-05	0.000395	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.86e-05	0.000394	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SRM—multiple sclerosis	3.82e-05	0.00039	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CD80—multiple sclerosis	3.79e-05	0.000387	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.78e-05	0.000386	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—POMC—multiple sclerosis	3.6e-05	0.000368	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.54e-05	0.000361	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.54e-05	0.000361	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCL2—multiple sclerosis	3.53e-05	0.00036	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—multiple sclerosis	3.47e-05	0.000354	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.000353	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.000353	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.39e-05	0.000346	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.38e-05	0.000345	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TYK2—multiple sclerosis	3.2e-05	0.000327	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—RRM1—multiple sclerosis	3.2e-05	0.000327	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.18e-05	0.000324	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.18e-05	0.000324	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000323	CbGpPWpGaD
Pentamidine—S100B—Immune System—MAPK1—multiple sclerosis	3.15e-05	0.000322	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.95e-05	0.000301	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.93e-05	0.000299	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.91e-05	0.000297	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—APOE—multiple sclerosis	2.79e-05	0.000284	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.73e-05	0.000279	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000275	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000275	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—multiple sclerosis	2.66e-05	0.000272	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.63e-05	0.000269	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000267	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—multiple sclerosis	2.52e-05	0.000257	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.48e-05	0.000253	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000251	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL6—multiple sclerosis	2.42e-05	0.000247	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.41e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—POMC—multiple sclerosis	2.39e-05	0.000244	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.28e-05	0.000232	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—multiple sclerosis	2.24e-05	0.000229	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ALB—multiple sclerosis	2.18e-05	0.000223	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.13e-05	0.000218	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—multiple sclerosis	2.08e-05	0.000213	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000212	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000212	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TGFB1—multiple sclerosis	2.08e-05	0.000212	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000208	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK1—multiple sclerosis	2.04e-05	0.000208	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.03e-05	0.000207	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.96e-05	0.0002	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.000199	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.94e-05	0.000198	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000194	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.84e-05	0.000188	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.78e-05	0.000182	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.69e-05	0.000172	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.59e-05	0.000162	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.58e-05	0.000162	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.000161	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—multiple sclerosis	1.57e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.5e-05	0.000153	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000141	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.36e-05	0.000139	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.24e-05	0.000127	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.00012	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOE—multiple sclerosis	1.11e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.01e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—POMC—multiple sclerosis	9.5e-06	9.69e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—multiple sclerosis	9.17e-06	9.35e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOE—multiple sclerosis	9.05e-06	9.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.05e-06	9.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—POMC—multiple sclerosis	8.71e-06	8.89e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—multiple sclerosis	8.66e-06	8.84e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.32e-06	8.49e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—multiple sclerosis	7.94e-06	8.1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—POMC—multiple sclerosis	7.77e-06	7.93e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—POMC—multiple sclerosis	7.15e-06	7.3e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—multiple sclerosis	7.09e-06	7.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.05e-06	7.19e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.52e-06	6.65e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.06e-06	6.18e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.52e-06	5.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.44e-06	5.55e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.67e-06	4.77e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.26e-06	4.35e-05	CbGpPWpGaD
